Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 20.65
-0.25 (-1.20%)
Jul 24, 2026, 5:00 PM CET
Celon Pharma Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Celon Pharma stock has a consensus rating of "Hold" and an average price target of zł 20.44. The average 1-year stock price forecast is 1.02% lower than the current stock price, while the lowest is zł 16.00 (-22.52%) and the highest is zł 25.50 (+23.49%).
Price Target: zł 20.44 (-1.02%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Celon Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
293.80M
from 242.21M
Increased by 21.30%
Revenue Next Year
288.73M
from 293.80M
Decreased by -1.72%
EPS This Year
-0.44
from -1.48
EPS Next Year
-0.18
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.